type here...

CATEGORIES

Mental Health

LATEST

1...222324...50Page 23 of 50

TRENDING

EDITORS CHOICE

Once-Resistant Rural Court Officials Begin to Embrace Medications to Treat Addiction

Medika Life -
DANDRIDGE, Tenn. — Rachel Solomon and judges hadn’t been on the best of terms. Then Judge O. Duane Slone “dumbfounded” her. Solomon was given...

HT World Correspondent and Medika Editor Gil Bashe Talks with the Medika50 Influencer Who Put Everything On the Line for Patients

Gil Bashe, Medika Life Editor -
HT World talks to the healthcare influencer who put everything on the line for patient advocacy on her mission to deliver change on many fronts.

A New A.I. Based Solution to Nurse Burn-out and Turnover

Medika Life -
What can we do to ensure that those we rely upon to care for us, are being supported in this essential, important work?

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories